Your browser doesn't support javascript.
Strategies at points of entry to reduce importation risk of COVID-19 cases and reopen travel.
Dickens, Borame L; Koo, Joel R; Lim, Jue Tao; Sun, Haoyang; Clapham, Hannah E; Wilder-Smith, Annelies; Cook, Alex R.
  • Dickens BL; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 1E Kent Ridge Rd, Singapore 117549.
  • Koo JR; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 1E Kent Ridge Rd, Singapore 117549.
  • Lim JT; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 1E Kent Ridge Rd, Singapore 117549.
  • Sun H; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 1E Kent Ridge Rd, Singapore 117549.
  • Clapham HE; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, 1E Kent Ridge Rd, Singapore 117549.
  • Wilder-Smith A; Department of Disease Control, London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London WC1E 7HT, UK.
  • Cook AR; Heidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 365, R. 004, 69120 Heidelberg, Germany.
J Travel Med ; 27(8)2020 12 23.
Article in English | MEDLINE | ID: covidwho-998402
ABSTRACT

BACKGROUND:

With more countries exiting lockdown, public health safety requires screening measures at international travel entry points that can prevent the reintroduction or importation of the severe acute respiratory syndrome-related coronavirus-2. Here, we estimate the number of cases captured, quarantining days averted and secondary cases expected to occur with screening interventions.

METHODS:

To estimate active case exportation risk from 153 countries with recorded coronavirus disease-2019 cases and deaths, we created a simple data-driven framework to calculate the number of infectious and upcoming infectious individuals out of 100 000 000 potential travellers from each country, and assessed six importation risk reduction strategies; Strategy 1 (S1) has no screening on entry, S2 tests all travellers and isolates test-positives where those who test negative at 7 days are permitted entry, S3 the equivalent but for a 14 day period, S4 quarantines all travellers for 7 days where all are subsequently permitted entry, S5 the equivalent for 14 days and S6 the testing of all travellers and prevention of entry for those who test positive.

RESULTS:

The average reduction in case importation across countries relative to S1 is 90.2% for S2, 91.7% for S3, 55.4% for S4, 91.2% for S5 and 77.2% for S6. An average of 79.6% of infected travellers are infectious upon arrival. For the top 100 exporting countries, an 88.2% average reduction in secondary cases is expected through S2 with the 7-day isolation of test-positives, increasing to 92.1% for S3 for 14-day isolation. A substantially smaller reduction of 30.0% is expected for 7-day all traveller quarantining, increasing to 84.3% for 14-day all traveller quarantining.

CONCLUSIONS:

The testing and isolation of test-positives should be implemented provided good testing practices are in place. If testing is not feasible, quarantining for a minimum of 14 days is recommended with strict adherence measures in place.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quarantine / Communicable Disease Control / Mass Screening / Communicable Diseases, Imported / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal subject: Communicable Diseases / Public Health Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Quarantine / Communicable Disease Control / Mass Screening / Communicable Diseases, Imported / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Language: English Journal subject: Communicable Diseases / Public Health Year: 2020 Document Type: Article